Cargando…
Dexamethasone for Inpatients With COVID-19 in a National Cohort
IMPORTANCE: Limited effective therapeutics are available to hospitalized patients with COVID-19. Clinical trials and observational studies have shown varying effects of systemic corticosteroids, including dexamethasone, in hospitalized patients with COVID-19, with limited descriptions of important p...
Autores principales: | Mourad, Ahmad, Thibault, Dylan, Holland, Thomas L., Yang, Siyun, Young, Allison R., Arnold Egloff, Shanna A., Thomas, Laine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111178/ https://www.ncbi.nlm.nih.gov/pubmed/37067800 http://dx.doi.org/10.1001/jamanetworkopen.2023.8516 |
Ejemplares similares
-
Clinical Outcomes Associated With Overestimation of Oxygen Saturation by Pulse Oximetry in Patients Hospitalized With COVID-19
por: Fawzy, Ashraf, et al.
Publicado: (2023) -
Takotsubo Syndrome in Black Americans: Insights From the National Inpatient Sample
por: Vriz, Olga, et al.
Publicado: (2023) -
COVID-19 Admission Rates and Changes in US Hospital Inpatient and Intensive Care Unit Occupancy
por: Meille, Giacomo, et al.
Publicado: (2023) -
Risk factors and electrocardiogram characteristics for mortality in critical inpatients with COVID‐19
por: Li, Lingzhi, et al.
Publicado: (2020) -
Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018
por: Early, Macy L., et al.
Publicado: (2023)